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Abstract
With increasing national health care expenditures, different methods of reducing health care
costs, along with supportive evidence-based research, are essential. This research will lead to
changes in clinical practice standards including the utilization of tools by emergency room and
hospitalist providers to reduce costs by decreasing the length of stay for acute chest pain
admissions. The researcher utilized a retrospective review of charts for participants admitted into
the acute care setting with the primary diagnosis of acute chest pain, with a focus on determining
whether an initial calculation of a HEART Score risk stratification variable was completed and if
there was a correlated relationship with reduced hospital length of stay. A total of 86 randomly
selected participant charts were reviewed, and a specific data set was collected as determined in
the methodology of the project. The analysis was completed by using Statistical Package for
Social Sciences (Version 24.0) software for the calculation of an independent samples t test,
which was used to analyze the differences between each acute chest pain admission, with and
without the HEART Score calculation, and the associated length of stay. The study analysis did
not support the hypothesis, as the null hypothesis was not rejected based on statistical findings.
Other study findings assisted in further development of health care changes for leaders,
managers, providers, and nursing teams. Further research should be conducted with a larger
sample size, in an institution with greater ethnic diversity, and with an additional qualitative
component to support the existing evidence-based research that supports a correlation between
the variables in this study.
Keywords: acute chest pain, coronary artery disease (CAD), HEART Score and pathway,
hospitalist provider, major adverse cardiac event (MACE)
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Chapter 1: Introduction
Health care expenditures are rapidly growing. The hospital inpatient acute care setting
contributes significantly to the growing health care costs. According to the Office of Disease
Control and Prevention (2018), “Heart disease is the leading cause of death in the United States .
. . [and one of] the most widespread and costly health problems facing the Nation today,
accounting for approximately $320 billion in health care expenditures and related expenses
annually” (para. 2). Health care providers must look at different methods of providing care,
eliminate unnecessary inpatient hospital days and expensive testing, and utilize tools to reliably
determine a diagnosis. In this study, I focused on one common admission that has proved costly
in the inpatient setting.
Statement of the Problem
Patients presenting with acute chest pain have increased health care costs in the process
of determining a diagnosis or cause for symptoms. The development of cardiac risk stratification
tools has provided new light on reducing health care costs by shortening the length of time from
presentation to diagnosis and from diagnosis to discharge. This study was guided by the
following question: For acute chest pain patients, does utilization of the HEART Score risk
stratification tool versus not using a cardiac risk stratification tool by a hospitalist provider
reduce hospital length of stay? With knowledge and practical application of these cardiac tools
during diagnosis, hospitalist providers can make a direct impact on reducing health care
expenditures while reliably and rapidly transitioning patients back to the outpatient setting.
Background of Problem of Interest
The health care system throughout the United States is heavily burdened by spiraling
costs. Patients with the chief complaint of acute chest pain are frequently admitted to the acute

2
care inpatient setting daily. Traditionally, health care spending is heavily weighted on
diagnostics related to the presentation of acute chest pain. Heart disease accounts for
approximately $320 billion in health care costs annually, including the costs accrued to obtain
diagnosis (Office of Disease Control and Prevention, 2018). Madder et al. (2011) projected that
millions present to the acute care setting yearly with the chief complaint of acute chest pain, and
it is estimated that 75% of these cases are determined to be non–cardiac related. They estimated
the cost of these inpatient non–cardiac-related “rule outs” average $6 to $8 billion annually.
Support is growing for a more rapid, cost-effective approach to expediting the diagnosis of
cardiac-related chest pain to reduce unnecessary health care expenses (Takakuwa, Halpern, &
Shofer, 2011). For the remaining 25% of cases, the presentation of chest pain can be lifethreatening if not recognized and acted upon immediately to avoid mortality or permanent
cardiac tissue injury.
Historically, patients with acute chest pain are admitted for unnecessary inpatient cardiac
testing to determine the cause of their symptoms. Hospitalist providers utilize labs, stress testing,
and cardiac catheterization results to guide their plan of care and aim to prevent lengthy hospital
stays. For many years, cardiac risk stratification tools were not available to determine the
meaning of pertinent factors for diagnosis of acute coronary syndrome (ACS). The basic
findings, without risk stratification tools, often led to more invasive testing, requiring additional
time in the hospital environment. The health care resources and expenditures to complete a
diagnostic workup exceeded necessary spending, leading to the development of risk stratification
tools to assist in categorizing these patients into different levels of risk for ACS (low, moderate,
or high).
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With high health care expenditures, including unnecessary and lengthy hospitalizations,
providers must have reliable data to utilize for patients with acute chest pain in order to safely
reduce their length of stay. If analyzed effectively, the hospitalist providers could reduce a large
part of these health care-related expenses annually. Hospitalist providers, working as the
patient’s inpatient primary care physician, are required to accept the admitted patients, analyze
the appropriateness of developed data, and complete interpretation of this information in order to
reduce a patient’s length of stay and safely discharge. With these data, the hospitalist provider
takes over the care, working closely with a consulted cardiologist, to determine the safest and
most cost-effective method of testing and treatment in the acute care setting. Many times,
decisions are based on cardiac risk stratification data to direct care appropriately from the
inpatient setting to the outpatient setting.
With this complex task, many cardiac-related risk stratification tools have been
developed since the 1980s. They have been rigorously tested since conception to increase
reliability and validity, with the goal of preventing major adverse cardiac events (MACEs). The
common tools that have been researched and placed into practice include the Thrombolysis in
Myocardial Infarction (TIMI), the Global Registry for Acute Coronary Events (GRACE), and the
History, Electrocardiogram, Age, Risk Factors, and Initial Troponin (HEART) Score. Extensive
research supports the appropriate utilization and application of these tools for developing a
patient’s risk of cardiac disease or an impending major event. After a review of the most current
evidence-based research, the HEART Score has been found to be the most reliable instrument
with a high level of validity designed to evaluate complaints of acute chest pain.
Hospitalist providers have different resources available to them in managing a patient
with acute chest pain. Nursing staffs utilize these tools to provide necessary education on
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HEART Score risk stratification findings and mentally prepare patients for rapid discharge to
reduce the length of stay. The entire nursing team providing care for the patient, whether on the
observation unit or in the inpatient setting, can use the results of the HEART Score risk
stratification tool to educate and appropriately prepare patients and family members based on the
data obtained. The results also provide significant information to the patient and family for
reducing their fears and stress related to the acute symptoms. This is critical education and
support that can directly impact a patient’s overall comfort in their transition of care from the
inpatient environment to the outpatient setting.
Purpose of Problem of Interest
I focused on a retrospective review of charts for acute chest pain patients admitted to the
hospitalist group within a 2-year period. The focus of this study was to determine whether an
initial cardiac risk stratification tool was utilized and if the data showed a reduction in a patient’s
length of stay. Significant findings led to further evidence regarding the use of the HEART Score
risk tool to shorten inpatient hospital stays, thus reducing inpatient health care expenditures.
Significance of the Problem of Interest
The goal for completion of this project was to add significant value and provide quality
evidence-based clinical approaches to support the use of the HEART Score risk stratification
tools to reduce hospital length of stay. The study provided further support for using risk
stratification tools for patients with acute chest pain in the inpatient hospital setting by
standardizing the response to an acute chest pain symptom. Through enhanced education on the
reliability and validity of the HEART Score tool, hospitalist teams have stronger evidence-based
knowledge in coordinating care and promoting the reduction of inpatient hospital days. This
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increased knowledge strengthens nursing education to promote health and reduce stress for the
patients and their families.
Through a careful review of analyzed data produced by this study, providers, case
management, and interdisciplinary team members (including all nursing teams) can obtain a
quantitative view of the efforts in managing health care costs while protecting the patients’ best
interests. Health care teams need to be aware of the pertinent data obtained from the HEART
Score and how to apply these data via education and care management for each acute chest pain
admission. Physicians have additional evidence-based support not only to enhance their quality
and safety of care decisions but also to promote the reduction of length of stay for each patient.
For administration, the findings related to effective utilization of the HEART Score data
and analyzed cost savings have historically been a large part of managing operations. This study
provided support for appropriate use of cardiac risk stratification tools through care planning,
policy changes, and education to safely reduce length of stay for this particular group of patients.
Administrative leadership can utilize these findings to support new policy and process
development in standardizing care in a safe and reliable approach toward all patients with acute
chest pain. As seen in this study, policies need to be updated to require providers and all
interdisciplinary team members to utilize and follow guidance from the HEART risk
stratification tool throughout the course of care for each patient.
Nature of the Project
Through the retrospective chart review of patients admitted with the chief complaint of
acute chest pain to the suburban community hospital with 288 beds, I analyzed the impact of
HEART Score on a patient’s length of stay and compared findings to patients in the same setting
and their length of stay without utilization of a cardiac risk stratification score. Patients with a
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low cardiac risk stratification score are often placed on 23-hour observation status. According to
HEART risk score guidelines, the hospitalist provider caring for the patient can effectively run
noninvasive testing to efficiently rule out ACS and discharge within this time frame.
A patient who has an elevated score on the HEART Score risk stratification tool is
predicted to have a higher risk for ACS and may need additional time in the acute care setting to
prevent MACE. Hospitalist providers must focus on these data and order appropriate testing at
the inpatient level without allowing for additional inpatient hospital days and unnecessary costs.
The HEART Score tool and the risk associations that are calculated can be clearly identified and
lead to reducing a patient’s length of stay in the acute care setting regardless of the score.
The sampling method was randomly selecting from all participants admitted during the
chosen time frame. There were two separate groups making up the independent variable: patients
who had a determined HEART Score risk stratification calculation and patients without cardiac
risk stratification scores. The dependent variable was patient length of stay, which was directly
influenced by the independent variable.
Research Question
Q1. For acute chest pain patients, does utilization of the HEART Score risk stratification
tool versus not using a cardiac risk stratification tool by a hospitalist provider reduce hospital
length of stay?
Hypothesis
The hospitalist provider can reduce a patient’s inpatient length of stay with the utilization
of the HEART Score risk stratification tool data.
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Theoretical Framework
The modified version of the theory of unpleasant symptoms serves as a foundation in the
management of care for patients with acute chest pain and related symptoms. Micolta, Genith,
and Torres (2015) linked three main components of this theory to nursing and health care
practice, including “the person’s experiences, the influencing factors that affect the nature of the
experience of symptoms, and the consequences” (p. 218). Within these three components lie
“physiological background, factors of physical, family and social environment . . . related to
work and domestic responsibilities, assuming roles, family support, and coping with their
difficulties, living with uncertainty and insecurity, relationships with the environment, and
complying with treatment” (Micolta et al., 2015, p. 218). The modified version of the theory of
unpleasant symptoms has received further support as it closely relates to influencing factors and
performance outcomes. The presenting symptoms are conceptualized as multidimensional,
including intensity, severity, quality, and timing. Timing is the most important for the patient,
provider, and overall health care team when managing cardiac-related symptoms (Knight et al.,
2016). All patients with such symptoms require treatment, support, and education regardless of
their resulting medical diagnosis. This theory allows for interpretation and definition of the
dimensions of presenting symptoms. At the same time, the influencing factors and consequences
can be identified to structure health care and develop a nursing intervention.
Operational Definitions
Acute chest pain. Acute onset of pain to the chest may be atypical or right sided, often
associated with shortness of breath, fatigue, diaphoresis, nausea, vomiting, dizziness, headache,
or radiation to the abdomen, back, shoulders, neck and/or arms (Bruno et al., 2015).
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Coronary artery disease (CAD). CAD is generally used to refer to the pathologic
process affecting the coronary arteries (usually atherosclerosis). It is sometimes used
synonymously with coronary heart disease (CHD) including the diagnosis of angina pectoris,
myocardial infarction, silent myocardial ischemia, and CHD mortality that result from coronary
artery disease. (Up to Date, 2019, para. 4)
Hospitalist provider. The hospitalist provider acts as the primary care physician within
the acute care hospital setting. For example, when the established outpatient primary care
physician for a patient does not have attending privileges or has contracted with the hospitalist
provider group, the hospitalist will take the role of the primary care physician in the acute care
setting. However, if a patient does not have an established outpatient primary care physician, the
hospitalist will provide care for the patient and assist them in becoming associated with an
outpatient primary care physician for appropriate follow-up after discharge (Shiel, 2019).
Major adverse cardiac event (MACE). MACE is defined as all-cause mortality,
myocardial infarction, or coronary revascularization. Many times, MACE will be calculated
during admission, within 3 to 6 months of initial acute chest pain presentation (Sanchis et al.,
2005).
Risk stratification. Risk stratification is an attempt to calculate the level of risk (low,
medium, or high) for patients presenting to the emergency room with acute onset of chest pain.
Multiple variables are rapidly measured including history, physical assessment,
electrocardiogram, and troponin level. These findings can be placed into different stratification
tools to calculate the risk factor and an immediate plan of care for ACS (Just, 2016).
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Scope of the Project
The study took place in the acute care inpatient setting. I focused on both male and
female patients, regardless of age, race, or ethnicity, who had been admitted with acute chest
pain for ruling out of ACS to the hospitalist program. I focused on a total of 86 patients admitted
to the hospitalist service between January 1, 2017, and December 31, 2018. The patients may or
may not have had comorbidities, which were not recognized as part of the study. However,
significant comorbidity that is measured in the HEART Score risk stratification tool is CAD, and
this was positively identified in the calculated risk score.
Chapter Summary
Acute chest pain patients are admitted frequently to the inpatient setting after presenting
to the emergency room. Patients undergo different cardiac diagnostic testing based on key
information from their family history, social history, and presenting symptoms. Many cardiac
risk stratification tools have been created over time to make the process of diagnosis rapid and
efficient while determining the nature of symptoms. Once admitted to the inpatient setting,
hospitalist providers utilize the available information, including the cardiac risk stratification
score, if available, from the emergency room. This project demonstrated the efficiency of testing
in ruling out cardiac-related chest pain during an admission to decrease the length of stay and
expedite patients to the outpatient setting for further nonemergent testing.
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Chapter 2: Literature Review
Evidence-based research is an important part of beginning any research study. The
literature review expands the knowledge of a health care topic and defines areas of further study.
For patients with acute chest pain, a number of risk stratification tools have been tried, tested,
and researched to efficiently diagnose ACS. These tools provide guidance in health care
decision-making to properly treat this high-risk disease. In this literature review, I take a closer
look at the research to support or refute three of the most utilized risk stratification tools used by
emergency room providers, hospitalist providers, and cardiologists. Valuable data have been
utilized to develop evidence-based support for how and when to appropriately use these tools.
In the search for pertinent evidence-based research, many different methods were utilized
to obtain appropriate research publications specific to this project. The following databases were
searched: MEDLINE/PubMed, CINAHL, ScienceDirect, Health Source: Nursing/Academic
Edition, Science and Technology Collection, Applied Science and Technology Source, Health
Source: Consumer Edition, Cochrane Database of Systematic Reviews, and Cochrane Central
Register of Controlled Trials. Each database was searched with the following words and phrases:
TIMI, critical pathways, HEART Score, length of stay, acute chest pain, emergency services,
cardiology services, hospitalist services, inpatient services, clinical prediction, MACE, heart
attack, acute myocardial infarction, acute coronary syndrome, high sensitivity, clinical
prediction, and diagnosis. Many different combinations of these words were used to bring
thousands of search results to hundreds. With a more reasonable search result, the articles
provided were more appropriate to this project.
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Thrombolysis in Myocardial Infarction
Thrombolysis in myocardial infarction (TIMI) is one risk stratification tool developed in
2000 with a score ranging from zero to seven. A score of zero equaled 5% risk for a 2-week
period to include all-cause mortality, myocardial infarction (MI), or severe ischemia requiring
emergent cardiac catheterization to reestablish heart flow (see Table 1). This tool was originally
created for different components of cardiac disease, including recurrent episodes of known CAD
and not specific to ACS (Sanchis et al., 2005). According to Backus et al. (2013), with proper
use of this tool, a provider identifies “risk of all-cause mortality, myocardial infarct (MI), and
severe recurrent ischemia requiring urgent revascularization within 14 days after admission” (p.
2154), suggesting that this tool is very easy to use although it has poor predictability, with a cstatistic of 0.65. This tool, along with most others, does not validate the patient’s history by
dedicating an adequate ranked score to account for factors, including hypertension,
hypercholesterolemia, diabetes, family history of CAD, or current smoking habits.
Table 1
TIMI Risk Stratification Tool
Factor

Identifiers

Age > 65

No (+0), Yes (+1)

> 3 CAD risk factors

No (+0), Yes (+1)

Known CAD (stenosis > 50%)

No (+0), Yes (+1)

ASA use in the past 7 days

No (+0), Yes (+1)

Severe angina (> 2 episodes in 24 hours)

No (+0), Yes (+1)

EKG ST changes > 0.5 mm

No (+0), Yes (+1)

Positive cardiac marker
No (+0), Yes (+1)
Note. Adapted from TIMI Risk Score for UA/NSTEMI, by E. Antman, 2000, retrieved from
https://www.mdcalc.com/timi-risk-score-ua-nstemi. Copyright 2010 by MDCALC. Adapted with
permission.
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The TIMI tool was not seen as an appropriate tool to be utilized in this study for patients
who present with low risk for ACS. The use of this tool in high-risk patients with ST-segment
deviations and/or elevated troponin levels provided a more reliable and validated risk
stratification score that took the following elements into consideration: different pain
characteristics, number of acute episodes of pain, atypical presentation of pain, patient age and
existing comorbidities, and history of CAD. Although this tool is aimed at different diagnostic
indicators, it has a 6.7% rate of MACE (Sanchis et al., 2005). Another study showed TIMI as an
inadequate tool for use in low-risk patients, leading to higher cost expenditures when utilized:
6396 patients with chest pain were evaluated. . . . 3751 [were] considered high risk of
short-term coronary events and were excluded from the study. . . . The remaining 2645
patients, with normal electrocardiogram (ECG), were admitted to our CP unit . . . 389
patients developed ischemic ECG changes, and/or abnormal troponins, and/or wall
motion abnormalities at echocardiography; all these patients were considered at high-risk
of coronary events and were referred for urgent coronary angiography. The work-up was
normal in 2256 patients. . . . 1435 were considered very low risk and were discharged . . .
whereas 798 were considered at low risk and underwent in-hospital ETT. Those with
positive EET (n = 142, 17.8%) were admitted, whereas those with normal ETT (n = 656,
82.2%) were discharged as very low risk patients. (Conti et al., 2010, p. 137)
As seen in this study, 82.2% of the patients accrued high health care costs after
completing unnecessary testing and were ultimately determined to be at low-risk for ACS. In one
other study, researchers found the use of TIMI risk score to be a moderate tool for original
diagnosis as compared to other tools found to be more adequate and cost-effective. Rania et al.
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(2018) studied “238 consecutive patients admitted for NSTE-ACS and who underwent coronary
angiogram during hospitalization” to calculate the severity of CAD (p. 41). TIMI scored p = .001
compared to GRACE, p < .001, with SYNTAX higher in patients at high risk and significant
clinical correlation between the tools to moderately predict obstructive CAD but not for severe
disease with sensitivity and specificity, GRACE 57%/61.8%, TIMI 75.7%/47.9%, with GRACE
recognizing disease in 120 of 238 and TIMI 2 of 238.
Jakimov et al. (2017) determined TIMI not to be an adequate tool to be used in the
emergency room setting, with a poor predictive ability secondary to limited utilization of
necessary tool elements to safely diagnose a patient with ACS. These findings were presented
after completing a single-center retrospective study of 200 patients after 30 days and the
predictive value of a MACE. These researchers compared the TIMI closely with the next tool
used for ACS risk stratification.
Global Registry for Acute Coronary Events
The global registry for acute coronary events (GRACE) is the second risk stratification
tool analyzed for this study. According to Backus et al. (2013), GRACE was developed in 2003
and has a score range of zero to 273, looking at the risk of inpatient death and potential death
within 6 months of discharge, with a predictive value of c-statistic 0.83. They determined this
tool to be “very complex,” with a high priority on patient age versus significant emphasis on
patient history, as seen with the TIMI.
Depending on the calculated score within this risk stratification tool, an automated
electronic measurement, the GRACE Score, was determined (see Table 2). A percentage was
determined to provide a probability of death from admission to 6 months (Grove & Fox, 1998).
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This complexity is difficult for emergency room providers, hospitalists, and cardiologists to
navigate rapidly and determine the need for immediate intervention.
Table 2
GRACE Score Risk Stratification Tool
Factor

Identifiers

Age

Number of years

Heart rate/pulse

Normal 60–100 beats/min

Systolic blood pressure

Normal 100–120 mm Hg

Creatinine

Normal 0.7–1.3 mg/dL

Cardiac arrest at admission

Yes/no

ST-segment deviation on EKG

Yes/no

Abnormal cardiac enzymes

Yes/no

Killip class (signs/symptoms)

No CHF, rales and/or JVD, pulmonary edema,
cardiogenic shock
Note. Adapted from GRACE ACS Risk and Mortality Calculator, by J. Grove & A. A. Fox, 1998,
retrieved from https://www.mdcalc.com/grace-acs-risk-mortality-calculator. Copyright 2011 by
MDCALC. Adapted with permission.
Jakimov et al. (2017) found GRACE to be a valid tool when utilized for a short time
frame and in two distinct groups, as evidenced in their single-center retrospective study of 200
patients after 30 days and the predictive value of a MACE. GRACE had the highest prognostic
ability, with a predictive value of c-statistic 0.73 compared to TIMI and RISK-PCI, another risk
stratification tool. Firdous and Malik (2017) found the GRACE Score was used in more with
patients who died in the acute care setting versus those who were discharged. They accurately
identified low-risk cases and correlated a low probability of death while overestimating death for
patients with diagnosed ST-segment deviation on EKG (STEMI). The GRACE Score was
reliable in identifying the risk category and adverse outcomes when utilized by clinicians. This
tool was recommended for utilization, as determined in their study looking at 165 patients with
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no identified history of cardiac disease. GRACE was shown to be a positive identifier, as 81.6%
of the patients had acute ST-elevated myocardial infarction (STEMI), thus leading to a high
percentage of participants (91.8%) with diagnosed ACS and 12.2% patient mortality during
hospitalization. This could be an indication that use of this tool could inadvertently raise health
care costs unnecessarily.
In summary, Firdous, Mehmood, and Malik (2017) found the GRACE tool to have
characteristics of overpredicting a patient’s likelihood of death, as found by completing their
study that looked at 165 patients with an overall GRACE predictability c-statistic of 0.913. The
use of this tool had little support for use with high-risk patient scores. As of a 2012 metaanalysis, researchers had found no stronger tool than GRACE or TIMI to use in the diagnosis of
ACS. GRACE was the only validated tool covering all types of ACS. GRACE (c-statistic = 0.82)
outperformed TIMI (c-statistic = 0.73) for short-term predictability, although other tools at this
time were slowly beginning to show higher potential for rapid short-term reliability (D’Ascenzo
et al., 2012).
History, Electrocardiogram, Age, Risk Factors, and Initial Troponin
The final tool and the leading tool for this project was analysis of the history,
electrocardiogram, age, risk factors, and initial troponin (HEART) Score. The HEART Score
was originally developed in 2008 and has been tested and proved superior to all other tools for
rapid analysis of acute chest pain in determining the predictability of ACS. The HEART Score
risk stratification tool applies a score ranging from zero to 10 and is actively utilized in
“prediction of the combined endpoint of MI, percutaneous coronary intervention (PCI), CABG
or death within 6 weeks after presentation” (Backus et al., 2013, p. 2154). Backus et al. (2013)
suggested many limitations, including wide confidence intervals, as found within their study
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conducted in their main location in the Netherlands, and varying emergency room score cutoffs
when determining discharge versus admission. This risk stratification tool has been validated
with extensive evidence-based research while positively identifying patients over the age of 21
who present with symptoms of ACS. The HEART Score risk stratification tool is used to look
closely at significant risk factors and comorbidities in combination with initial testing, including
cardiac enzymes and an initial electrocardiogram (ECG or EKG). The predictive ability has been
proved by the following MACE scores: A score of 0–3 represents 0.9%–1.7% risk, a score of 4–
6 represents 12%–16.6% risk, and a score of ≥ 7 represents 50%–65% risk of an adverse cardiac
event (see Table 3; Backus, 2008).
Table 3
HEART Risk Stratification Tool
Factor

Identifiers

History

Slightly suspicious (+ 0), moderately suspicious (+ 1), highly suspicious
(+ 2)

EKG

Normal (+ 0), nonspecific repolarization disturbance (+ 1), significant ST
depression (+ 2)

Age

< 45 (+ 0), 45–64 (+ 1), > 65 (+ 2)

Risk factors

No known risk factors (+ 0), 1–2 risk factors (+ 1), > 3 risk factors (+ 2)

Initial troponin

Normal (+ 0), 1–2 times normal limit (+ 1), > 2 times normal limit (+ 2)

Note. Adapted from HEART Score for Major Cardiac Events, by B. Backus, 2008, retrieved
from https://www.mdcalc.com/heart-score-major-cardiac-events. Copyright 2013 by MDCALC.
Adapted with permission.
According to Firdous, Mehmood, and Malik (2017), a study of 165 patients utilizing the
GRACE risk score in acute chest pain patients presenting to the emergency room showed that
“GRACE risk score is an effective and valid tool, but it has some tendency of overestimating
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probability of death following ACS and may require a fine tuning in some cases” (p. 600).
Another study indicated appropriate evidence-based management of patients with different
scores, indicating that a patient with a HEART Score of 0–3 has a 1.7% risk of MACE over the
following 6 weeks from presentation and indicating discharge from the emergency department as
determined following a review of 2,440 unselected chest pain patients from 10 different hospitals
(Backus et al., 2013). Ultimately, they found this risk stratification tool a “quick and reliable
predictor of outcomes in presenting chest pain patients” (Backus et al., 2013, p. 2155).
Supporting these studies, one systematic review, one meta-analysis, and 11 studies all showed
HEART Score to be one of the strongest tools available when predicting and diagnosing ACS in
relation to the symptom of acute chest pain (Parenti, Agrusta, & Luciani, 2016). This review
suggested that the HEART Score tool is used efficiently in determining appropriate management
of the common acute chest pain complaint, with only 25% of these complaints diagnosed as
coronary heart disease.
In one final study, researchers determined predictability in early discharge from the
emergency room when using the HEART Score risk stratification tool. Mahler et al. (2013)
indicated that the HEART Score has high sensitivity and reliability when categorizing a large
number of patients as low risk, which supports discharge straight from the emergency room.
They tracked these findings by analyzing 1,005 patients with a 30-day initial presentation and
found the HEART Score to clearly identify 20% of these patients as low risk, with a 99%
sensitivity of no MACE within the 30-day window. This evidence-based research, along with
many other reliable research findings, strongly supports the HEART Score and pathway as the
risk stratification tool of choice for rapid and safe decision management, along with large health
care cost savings across emergency rooms and inpatient settings worldwide.
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Length of Stay
With confidence in the reliability of the HEART Score tool, I took a look at how this tool
impacted different areas of health care, including the reduction of health care expenditures. The
concept of regulating patient length of stay in the acute care environment has become important
in managing health care costs. Many insurance companies including Medicare have linked a
specific length of stay deemed acceptable when funding an admission with certain diagnosis
(e.g., acute chest pain). The HEART Score tool provides specific information as to the risk that a
patient has upon presentation with the symptom of acute chest pain. This information was
properly utilized in reducing inpatient hospital days with the transition of nonemergent testing to
the outpatient setting without compromising patient safety. Once admitted to the hospitalist
group, a patient is linked with the concept of length of stay, and this must be managed
appropriately to avoid unnecessary health care costs.
According to the research completed, one group of researchers suggested that with a
HEART Score equal to or less than 3 along with high-sensitivity troponin, a patient had a
predictive value of 99.5% or higher, indicating discharge directly from the emergency room
(Carlton, Khattab, & Greaves, 2015). Another group of researchers found similar support with
appropriate guidance for reducing the length of stay. Hyams et al. (2018) screened 625 chest pain
patients and analyzed results from many different demographics, including the HEART Score
tool. They determined that admission rates were 63.5% (95% confidence interval [CI] [58.7,
68.2]) prior to applying the HEART Score tool. With the application of the tool, the admission
rate was lowered by 48.3% (95% CI [43.7, 53.0]).
A patient’s length of stay becomes a red flag when patients are admitted with a low
HEART Score. Poldervaart et al. (2016) conducted a study that determined that the HEART
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Score tool was superior to TIMI and GRACE scores when ruling out MACE indicators and
determining the highest-level safety and low-risk patients presenting with chest pain. The
HEART Score was used to identify 381 of 1,748 patients in the study as low risk, with 0.8% of
the 381 participants identified as MACE after the score was obtained. When a patient with a low
HEART Score is admitted into the hospital, it becomes important for the hospitalist provider to
utilize the HEART Score data and confidently reduce their length of stay by avoiding
unnecessary health care expenditures in the acute care setting.
Conceptual Framework Discussion
More than 5 million patients annually present to emergency rooms throughout the United
States with acute chest pain and other associated symptoms and are evaluated for ACS with an
overwhelming fear of disease, which impacts their functional status and quality of life (Knight et
al., 2016). This project presented the following question: For acute chest pain patients, does
utilization of the HEART Score risk stratification tool versus not using a cardiac risk
stratification tool by a hospitalist provider reduce the hospital length of stay? With a variety of
symptoms, of which the most typical is left-sided chest pain, a patient experiences a realm of
emotion and stress, fearing death or a severe cardiac disease-causing life-limiting outcome. The
hospitalist provider and the nursing staff must act quickly to make medical management
decisions. They must also provide support to relieve and calm symptoms: “The role of symptoms
in patients’ quality of life and functional status has been identified as a key area of inquiry to
support high-quality, patient-centered health care” (Knight et al., 2016, p. 269). The modified
version of the theory of unpleasant symptoms served as a foundation in the management of care
for patients with acute chest pain and related symptoms in this study.
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In one particular study, researchers looked closely at the theory of unpleasant symptoms
and the different symptoms that correlate with ACS, including the psychological aspects of
distress. This dimension was qualified as depression and/or fatigue when faced before, during
workup, or after diagnosis of ACS. Fatigue was an aspect of distress that was used as an example
of providing a conceptualization of this theory (see Figure 1; Eckhardt, Devon, Piano, Ryan, &
Zerwic, 2014). In another meta-analysis, researchers compared a different component of the
theory by defining unpleasant physical symptoms that may trigger psychological concern for
ACS, including “classic” symptoms of chest pain or discomfort, discomfort in other areas of the
upper body, shortness of breath, sweating, nausea, and light-headedness, as well as less typical
symptoms of fatigue, palpitations, indigestion, and pain in other areas (Knight et al. 2016).
Although there is a disease-centered approach to ACS symptom management, different risk
stratification tools are valuable in reducing morbidity, mortality, and health care–associated
costs, as well as tools to help nursing teams manage different components related to acute
symptoms. The individualized patient outcomes and concepts of quality of life in managing
unpleasant symptoms are a defining component in health care intervention development and
decision-making that must also play a key role in provider care.
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Figure 1. Conceptual view of the theory of unpleasant symptoms with fatigue. This presents a
systematic, qualitative approach through qualitative interviews and questionnaires to
comprehend essential patient experiences. The approaches included psychological,
physiological, and situational components in the presence of fatigue associated with coronary
heart disease and a potential impending ACS event. The Fatigue Syndrome Inventory (FSI)
provided by Hann, Denniston, and Baker (2000), as cited in Eckhardt et al. (2014), was utilized
to provide structure regarding the experience of the symptom of fatigue. Short Form-36 (SF-36),
provided by McHorney, Ware, and Raczek (1993), was presented in Eckhardt et al. (2014) and
provided a questionnaire of 36 items that enabled researchers to identify how fatigue impacted a
person’s quality of life both physically and mentally. Adapted from “Fatigue in the Presence of
Coronary Heart Disease,” by A. Eckhardt, H. DeVon, M. Piano, C. Ryan, and J. Zerwic, 2014,
Nursing Research, 63(2), p. 84. Copyright 2014 by Wolters Kluwer Health in Lippincott
Williams & Wilkins. Adapted with permission.
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With confidence in the reliability of the HEART Score tool, it is necessary to take a look
at how this tool can impact different areas of health care, including reduction of health care
expenditures. The concept of regulating the length of stay in the acute care environment has
become important in managing health care expenditures. Many insurance companies, including
Medicare, have linked patients with the specific length of stay acceptable when being admitted
with a certain diagnosis. The HEART Score tool provides specific information as to the risk that
a patient has upon presentation with acute chest pain. Is it necessary for all acute chest pain
patients to be admitted for further testing and observation? Can a patient with a low HEART
Score be safely discharged from the emergency room with no coordinated length of stay and
complete follow-up in the outpatient setting? When admitted, a patient is then linked with the
concept of length of stay.
According to research conducted by Carlton et al. (2015), at least 30% of individuals can
be determined safe for discharge from the emergency room. The researchers suggested that for
patients with a HEART Score equal to or less than 3 along with high-sensitivity troponin,
established as part of the score, there is a high validity and reliability for immediate discharge. In
another study, researchers found similar findings with appropriate guidance for reducing the
length of stay. Hyams et al. (2018) screened 625 chest pain patients and looked at results from
many different demographics including the HEART Score tool. They determined that admission
rates were 63.5% (95% CI, [58.7, 68.2]) prior to applying the HEART Score tool. With the
application of the tool, the admission rate was lowered by 48.3% (95% CI, [43.7, 53.0]). The
importance of length of stay becomes a focus when patients are admitted with a low HEART
Score. Poldervaart et al. (2016) determined that the HEART Score tool was found superior in
identifying patients at risk versus not at risk of MACE, with strong indicators of low-risk
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individuals. The HEART Score identified 381 of 1748 patients in the study as low risk, with
0.8% incidence of missed MACE. When a patient with a low HEART Score is admitted into the
hospital, it becomes important for the hospitalist provider to utilize the HEART Score data to
confidently reduce one’s length of hospital stay and avoid unnecessary inpatient health care
expenditures.
Chapter Summary
After review of all three of these risk stratification tools and the theory of unpleasant
symptoms, there is clearly room for more evidence-based research to promote the use of
practical application of tools to reduce the length of stay and unnecessary expenses. Many
providers utilize different aspects of these tools to determine their own comfort level in early
discharge for acute chest pain patients. With large diversity among different institutions, the use
of one specific tool to safely arrive at a diagnosis of ACS is pertinent to health care savings
through reduction of length of stay, unnecessary testing, and improvement in the overall quality
of care. One efficient and effective risk stratification tool can help support nursing practice in
educating patients on evidenced-based research and proper management of unpleasant
symptoms. Backus et al. (2013) suggested that there is still need for evidence-based research
with statistically significant results to support the national use of the HEART Score risk
stratification tool for diagnosis and plan of care development for patients with acute chest pain.
In this project, I looked closer at the use of the HEART Score tool as a cost-saving method to
reduce inpatient length of stay.

24
Chapter 3: Research Method
Many patients are admitted to the hospital with acute chest pain. After admission,
additional testing to determine the cause of presenting symptoms is used and extends the amount
of time spent in the acute care setting. Risk stratification tools have been determined helpful in
reducing the length of stay for acute chest pain patients by moving nonemergent testing to the
outpatient setting. In this project, I evaluated for a decrease in the length of stay by utilizing the
HEART Score risk stratification tool in the hospital environment.
Project Design
This project was based on a quantitative retrospective chart review of 86 patients
admitted to the hospitalist service at a suburban community 288-bed hospital in Central Florida.
Patients were admitted to the hospitalist service between January 1, 2017, and December 31,
2018, with the primary diagnosis of acute chest pain. The chart review was used to first analyze
whether or not a HEART Score was initially calculated for the patient in the emergency room
before admission. Each HEART Score was validated for accuracy by utilizing the QxMD
HEART Score mobile application. Authorization to utilize this tool was received using mobile
downloads of the application with acceptance of terms and conditions I completed.
At this point in the study, I tracked the level of board certification obtained by the
medical professional calculating the original score as created by a physician, a physician
assistant, or a nurse practitioner. Each patient had a determined length of stay obtained from
hospital statistical data linked to the participant. Finally, after data collection was completed, I
used the independent samples t test and multiple descriptive studies in the Statistical Package for
the Social Sciences (SPSS) software to complete the analysis. By analyzing the different
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components of a chart, data were obtained to determine if the initial HEART Score led to
reduced length of stay.
Measurement Tool and Data Collection
In this study, I analyzed whether or not the patient chart contained a HEART Score
calculated before admission. The HEART Score takes the following into consideration: the
initial EKG findings, the patient’s age, their associated risk factors, and the initial troponin.
Through previously discussed research, the predictive ability has been determined by identifying
scores significant for MACE: A score of 0–3 represents 0.9%–1.7% risk, a score of 4–6
represents 12%–16.6% risk, and a score of ≥ 7 represents 50%–65% risk of an adverse cardiac
event (Table 3; Backus, 2008). For some participants in this study, the HEART Score instrument
was utilized to calculate the appropriate predictive value of MACE based on the provided
information. For patients without a HEART Score value calculated in the emergency room, there
was no prediction of MACE.
Each chart with a calculated HEART Score underwent additional analysis to confirm the
validation of these data. This was completed by utilizing a mobile application instrument, which
allowed me to quickly analyze the data and calculate an accurate HEART Score by using the
QxMD mobile application developed and authorized for use by QxMD Medical Software
Incorporated (see Appendix A). This application has been validated by many users and simplifies
the process of applying the HEART Score risk stratification tool when quickly assessing a
patient complaining of acute chest pain in the emergency room (Backus et al., 2010). This
application can also be used by hospitalist providers on patients who are admitted without a
HEART Score determined in the emergency room. Once verification of the HEART Score for
accuracy was completed, the participant remained in the study. For those charts that were
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reviewed and had an inaccurate calculation of the HEART Score, they were excluded from the
study.
One additional component that I collected was the professional level of licensure
completing the HEART Score calculation of the original chart in the emergency room. Each
chart that contained a HEART Score and remained in the study was reviewed to determine
whether a physician (medical doctor or doctor of osteopathy) or health care provider (nurse
practitioner or physician assistant) calculated the HEART Score upon presentation. This was
then calculated as a percentage at the end of the study. This additional information could be
useful for administration or medical management and leaders to review and could potentially
lead to policy changes requiring all providers to utilize this tool for accuracy and completeness in
the initial acute chest pain workup.
Data tracking tool. I created a tracking tool to break down participants into different
categories. If the hospitalist were utilizing the HEART Score, the data would have proved that
the length of stay had decreased. Those without a HEART Score were expected to have an
increased number of tests, requiring a longer length of stay to safely rule out differential
diagnoses for the cause of their chest pain.
The tool developed to collect data for this project broke down into the following
components. First was determining the presence of a cardiac risk stratification score. Patients
with a calculated HEART Score were labeled “1” and patients without a HEART Score were
labeled “2.” Second, each participant had a specific length of stay. The following breakdown was
used to quantify the length of stay for each participant: observation or 23-hour admission = 1,
admission greater that initial 23 hours but less than 2 full days = 2, admission greater than 2 full
days but less than 3 full days = 3, and admission greater than or equal to 3 full days = 4. Finally,
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the provider category included participants with a completed HEART Score and determined the
level of licensure behind the provider calculating this variable. This was recorded into three
different categories including a medical doctor / doctor of osteopathy, a physician assistant, or a
nurse practitioner. Additional demographic information was collected including patient ethnicity,
age, and gender. This information provided additional support to the validity and reliability of
the HEART Score risk stratification tool, its utilization, and the importance of identifying ACS,
as these demographics can link a particular patient to a higher risk upon presentation.
Reliability and validation. The reliability and validation of the data collected and used
to create the project tool were heavily dependent on accurate chart review. Each chart took
approximately 60 to 90 minutes to review. During this review process, only pertinent data were
obtained to strengthen the reliability of the instrument. All patients admitted to the hospitalist
service with acute chest pain with the linking ICD-10 and CPT codes were included in the
original sample of the project.
During the review process, confirming proper calculation of the HEART Score based on
patient-provided information completed validation. There were cases where the emergency room
provider had not properly calculated the HEART Score, and these cases were excluded from the
study. All patients who had not been assigned a HEART Score in the emergency room were
included in the original sample. Any patient determined to have an acute STEMI in the
emergency room was excluded from the study. Any patient determined to have a non-ST
segment elevation (NSTEMI) with elevated troponin was excluded from the study. This study
was primarily focused on all acute chest pain patients regardless of existing comorbidities, such
as hypertension, diabetes, congestive heart failure, or end-stage renal disease.
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In defining key analysis terms, Vassar and Holzmann (2013) described intrarater and
interrater reliabilities as statistical estimates measuring coding accuracy, with intrarater
reliability calculating the findings that differ between variables when analyzed by the same
abstractor. Interrater reliability is determined by multiple variables forming the same result or
code, and if not present, this measurement indicates a level of error present. For this study, the
primary researcher consistently completed all data collection and data analysis, therefore
confirming intrarater and interrater reliabilities. The developed instrument assisted in confirming
all data were collected and assigned consistently. Vassar and Holzmann (2013) reported,
The retrospective chart review (RCR), also known as a medical record review, is a type
of research design in which pre-recorded, patient-centered data is used to answer one or
more research questions. The data used in such reviews exist in many forms: electronic
databases, results from diagnostic tests, and notes from health service providers. (p. 1)
For the purposes of this study, participant charts were randomly selected between January
1, 2017, and December 31, 2018, based on the primary admitting ICD 10 R07.9, CPT code
786.50. According to the most up-to-date ICD-10 coding, R07.9 includes approximate
synonyms:
•

chest pain

•

chest pain on exertion

•

chest pain, localized

•

exertional chest pain

•

localized chest pain

and clinical information with associated symptoms
•

nausea
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•

diaphoresis

•

fatigue

•

dizziness

•

shortness of breath. (ICD 10 Data, 2019, para. 2)

The chart review was electronically reviewed. The first focus was on the emergency
room provider documentation with evidence of a calculated HEART Score or to determine if no
identified risk stratification tool was utilized. Finally, patients had a specific length of stay during
their admission. The data collected from reviewing each patient’s chart were used according to
the instrument created above and placed into an Excel document for proper analysis.
Management and Analysis of Data
The management of data in this study was pertinent to the privacy of each participant.
The participant charts were identified by the primary admitting diagnosis of acute chest pain,
ICD 10 code R07.9 with CPT code 786.50. The medical director of the participating site
provided access to all participant charts. All patients admitted during the allocated time frame
had the potential of being randomly selected for this project. The medical director randomly
selected 86 charts for purposes of the study by selecting from a list of patient admission case
numbers. This was not specific to the time of day, day of the week or month, or year. Vassar and
Holzmann (2013) reported,
Random sampling is the gold standard of these techniques. Elements from the population
are selected at random, meaning that each medical record has an equal opportunity of
being selected for coding. Random selection accounts for sampling bias and permits
researchers to generalize their results to the population from which the sample was
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drawn. . . . Confidentiality and ethics in medical research are a very serious and a highly
regulated field, both institutionally and through the Federal government. (pp. 10–12)
For this study, the medical director and I had access to the individuals’ personal health
information and identifiers. Each patient chart, randomly selected, was labeled with a case
number. A master list of selected case numbers was maintained by the lead researcher in a
secured electronic format in the hospital computer system throughout the study and was
destroyed at completion. During the analysis and presentation of data, the case number was the
only participant identifier and did not reveal specific patient information, such as name, social
security number, address, phone number, or date of birth. This study focused only on the
HEART Score assigned or not assigned, length of stay, gender, age, and ethnicity of each
participant. There was no indication for additional identifiers for participants included in this
study.
This project required appropriate approval and release of charts for review. For approval,
the medical director of the contracted hospitalist group provided approval of all data collection
and support of this study (see Appendix B). The director was also the point of contact and
considered a coinvestigator for random chart identification, for any questions related to the data,
and for charts that could not be accessed. The contracted hospitalist group had been present in
this location since the hospital’s inception and continued to manage approximately 60% of all
patients admitted to the hospital for care, regardless of diagnosis, as presented by the hospital
administration in 2019. All participants released for review during this project had been admitted
to the hospitalist service under primary internal medicine care. Consent to access selected
participant charts was received before data collection from the medical director and the hospital
lead administrator (see Appendix C).
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Methodology—Statistical Analysis
The sample size was determined by completing a power analysis. For this study, the
power analysis was completed utilizing a mobile application that allowed for one sample test
mean to be completed with a type I/II error rate of alpha 0.05, power of 80%, true mean () of 2,
a null hypothesis mean (0) of 1.5, a standard deviation () of 1, and a p value of .05, or 5%. The
calculated sample size appropriate for this study was 86 participant charts (Creative Research
Systems, 2012).
An independent samples t test was used to analyze the differences between acute chest
pain admissions and the associated length of stay. The second analysis was a descriptive study
looking at the specific demographics of each participant. Both analyses were completed through
SPSS (Version 25.0) software to support this project. According to Vassar and Holzmann (2013),
“RCRs, the operationalization of variables, occur through two steps. The first process that must
occur a priori is identifying and defining the study variables” (p. 6). The variables for the
independent t test analysis in this study included the following:
•

independent variable: HEART (history, ECG, age, risk factors, troponin) Score or no
cardiac risk score

•

dependent variable: length of stay (scale level of data)

With the identified independent variable and the dependent variable, the appropriate
statistical test for this project was the independent t test. According to Moran, Burson, and
Conrad (2014), the independent t test provides the t value that “determines if there is a statistical
significance between the two mean groups” (p. 266). The degrees of freedom (df) is “the number
of independent pieces of information that went into calculating the estimate” (Glen, 2013, para.
1).
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Another pertinent value provided from this analysis was the p value, p = .05. The
probability assisted in answering the hypothesis and suggested that a patient had a decreased
length of stay with the utilization of HEART Score when being admitted for acute chest pain.
The null hypothesis for this study supported that the use of the HEART Score did not reduce the
length of stay for patients admitted for acute chest pain. Therefore, after the application of the
independent t test, there were two possible outcomes: If the p value were less than .05, or 5%, I
would fail to reject the null hypothesis, and the study hypothesis would be significantly
supported by the research. But if the p value were equal to or greater than .05, the findings would
be determined not statistically significant in supporting the use of the HEART Score to decrease
the length of stay, and I would accept the null hypothesis.
Feasibility and Appropriateness
This project offered easy and cost-effective methods to make the study feasible and
appropriate. With the overall goal of achieving cost-effective outcomes, appropriate time and
cost were applied to determine beneficial health care savings that come from reducing the length
of stay for any patient in the acute care setting. This project was more heavily weighted on
researcher time than on costs. Administrative costs were limited, as the data, data analysis, and
processing of findings were computer based. I designed the study most appropriate for the acute
care setting by proficiently using the electronic medical record that already existed.
IRB Approval and Process
This study began once IRB approval had been received. The process of obtaining IRB
approval included the completion of the required IRB training with an appropriate passing grade
and the submission of the project proposal for defense to the IRB. Once the proposal had been
accepted and a letter was received releasing the study from further IRB requirements, I then
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submitted the IRB exception (see Appendix D) to Abilene Christian University (ACU) under the
supervision of an ACU faculty chair who agreed to act in this role. After completing this portion
of the IRB review process with approval and exception received, data collection and analysis
were completed.
Interprofessional Collaboration
A very important component of this project was the focus on the interprofessional
collaboration that existed within the acute care setting and specifically within the hospitalist
team. DNP Essential II: Organizational and Systems Leadership for Quality Improvement and
Systems Thinking and DNP Essential VI: Interprofessional Collaboration for Improving Patient
and Population Health Outcomes brought structure to the need for communication across health
care and nursing teams working together to improve patient quality and safety (American
Association of Colleges of Nursing, 2006). This researcher worked to improve overall provider
management within the hospitalist team and provided pertinent data to improve patient outcomes
without spending unnecessary additional time in the acute care setting. The theoretical
framework that was directly tied to this project lends nursing support to further patient education
on cardiovascular health and to improve overall population health.
There was also significant interprofessional collaboration in the academic setting to
support this research project. Multiple professors throughout the ACU DNP program facilitated
leadership and shared knowledge to accelerate learning to complete this project. The DNP
program director, project chair, and multiple committee members worked collaboratively with
me to properly collect, analyze, and interpret data. This was completed through project drafting
and presentation of the literature review and findings.

34
Practice Setting
The practice setting for this project was primarily the acute care setting. All participants
had been admitted to a private for-profit community hospital with acute chest pain as the primary
diagnosis. This hospital is located on the gulf coast of central Florida. The goal was to reduce the
length of stay by referring patients to complete nonemergent cardiac testing in the outpatient
setting.
Target Population
The target population was randomly selected and consisted of adult patients 18 years of
age and older, regardless of gender, who had been admitted for acute chest pain between the
dates of January 1, 2017, and December 31, 2018. The participating community hospital
assigned these adult-age patients upon admission to the contracted hospitalist team as their only
attending providers throughout each admission. The study took into account each participant’s
age, gender, and ethnicity. Participants with multiple admissions for the same diagnosis were
excluded from the study along with participants who were admitted from the emergency room
with an inaccurate HEART Score.
Risk/Benefit
As this study was based on a retrospective chart review and all patients had been
discharged, there was minimal identified risk to the participants. With proper protection and
privacy given to all participants during the research, there were no personal identifiers utilized in
the data analysis or transmission of findings. The risk was limited from the project with the
appropriate methods of data collection as previously discussed.
Although there were few associated risks during this study, there were risks presented to
the participants, providers, nursing teams, and hospital organization after completing the study.
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Participants were at physical risk if the appropriate information and documentation were not
collected in the emergency room or while admitted, leaving patients with the potential for
undiagnosed ACS. Provider documentation and lack of quality data became another concerning
finding after reviewing the collected data. Providers left themselves and their nursing team at
legal risk when the standard information for ruling out ACS was not appropriately charted.
Finally, there was a large economic risk that became apparent for the hospital organization. All
patients who participated in this project were admitted under an observation or inpatient status
without appropriate risk stratification occurring in the emergency room. These hospital
admissions may not have been necessary with the potential for safe discharge and reduction of
cost by processing appropriate discharge from the emergency room back into the community for
necessary nonemergent testing.
The benefits of the study greatly outweighed any potential risk that had not been
considered. The main benefit obtained with the completion of the study was the reduction of
health care costs by reducing the length of stay in the acute care setting and avoiding any
nonemergent testing to future patients. With successful findings, the hospitalist provider obtained
evidence-based research to appropriately adjust its practice to benefit patients and reduce health
care–related expenditures. The nursing team benefited with additional evidence-based
information to provide to their patients and enhance their educational skills.
Timeline
This study data collection and analysis was completed over 4 months. Once IRB
exception had been obtained, data collection began. Data collection and instrument development
for each participant was the most time-consuming factor within these 4 months. Once completed,
data analysis was completed and shared with the DNP project committee. A final DNP project
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defense presentation was made to the DNP program director, the project chair, and the project
committee for approval of the entire study and approval to move to the final steps of editing and
publishing this research project. Finally, the publishing of the completed study required
additional time and support from the DNP project committee. The overall project timeline,
starting back to January 2018, has been provided and identifies multiple project milestones up to
the end of project and final approval (see Appendix E).
Chapter Summary
Through a quantitative randomly selected retrospective chart review and the independent
samples t test in SPSS, the goal of this study was to determine comparisons between using the
HEART Score risk stratification tool versus no cardiac risk score and the reduction of length of
stay in a suburban community hospital. The data provided a specific yes or no response to the
hypothesis. This approach will strengthen support for identifying hospitalist providers’
inappropriate management of diagnosis, treatment, and discharge for these specific patients and
providing health care cost-saving approaches.
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Chapter 4: Results
This project was a retrospective chart review to study the impact of utilizing the HEART
Score risk stratification tool on a patient’s length of stay when admitted with acute chest pain.
The data analysis used for this project was the independent samples t test using SPSS (Version
25.0). I did not find statistical significance from the small and disproportionate sample sizes
between the comparison groups. Many other significant findings and inferences were obtained
from the study and supported moving forward in the future with the expansion of research on this
subject.
Project Analysis
Through the completion of a retrospective chart review, I collected pertinent admission
documentation, participant length of stay (LOS), and diagnosis data. Analysis of the information
was completed to provide evidence-based research supporting the research question and stated
hypothesis. The research question was as follows: For acute chest pain patients, does the
utilization of the HEART Score risk stratification tool versus not using a cardiac risk
stratification tool by a hospitalist provider reduce the hospital length of stay? The assumption
with our hypothesis stated that there is significant statistical value from utilizing the HEART
Score risk stratification tool in reducing a patient’s LOS when admitted with the primary
diagnosis of acute chest pain. After analysis of the data, the study did not show a significant
statistical difference between those participants with a calculated HEART Score versus those
who did not have a documented risk stratification score. Therefore, I accepted the null hypothesis
that assumed the LOS was not significantly changed by the utilization of the HEART Score risk
stratification tool.
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Discussion of Demographics
The study was conducted with a sample size of 86 participants. One participant left the
hospital following admission against medical advice without further testing being completed.
The following demographics outline the remaining 85 participants in the original sample for the
DNP project.
Age. The sample size had an average participant age of 58 years, with the youngest
participant at 32 years and the oldest participant at 90 years of age. According to the HEART
Score tool breakdown, 17% of the participants were less than the age of 45, 51% were between
the ages of 45 and 64, and 32% of the original sample size was over the age of 65. Of the
patients who had a HEART Score calculated on admission, the average age was 59, with a
median age of 50. The oldest participant with a calculated HEART Score was 74 years old, and
the youngest participant was 32 years of age. Age differences are shown in Table 4.
Table 4
Age
Group

Participants

Percentage of sample size

< 45 years

15

17%

45–64 years

44

51%

> 65 years

27

32%

Gender. The sample size was represented by an adequate amount of gender difference.
There were more females in the study, with 52.3% representation, and fewer males, with only
47.7% participation. Of the patients who had a HEART Score calculated on admission, 67% of
the scores were for males and 33% were for females. Gender differences are shown in Table 5.
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Table 5
Gender
Gender

Participants

Percentage of sample size

Female

45

52.3%

Male

41

47.7%

Ethnicity. This study was conducted in a growing suburban community with a prominent
Caucasian population with minimal diversity. The population demographics relating to ethnicity
were properly represented in the sample of 80% Caucasian participants. The remaining 20% of
the ethnic diversity present in the sample included Hispanic persons (9%), African Americans
(6%), and Asians, Indians, and people of other ethnicities (5%). The portion of the sample size
that received a calculated HEART Score in the emergency room was 100% Caucasian ethnicity.
Ethnicity differences are shown in Table 6.
Table 6
Ethnicity
Group

Participants

Percentage of sample size

69

80%

African American

5

6%

Hispanic

8

9%

Other (Asian, Indian, etc.)

4

5%

Caucasian

Providers. On any given day within the emergency room, there is a specific ratio of one
physician to two health care providers (physician assistant or nurse practitioner). In this study,
the random sample selection had a higher physician presence than health care provider
representation. Eighty percent of the participants were initially evaluated for chest pain and
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treated by a medical doctor (MD) or a doctor of osteopathy (DO). A health care provider cared
for the remaining 20% of the sample population, with physician assistants more prominently
represented. Of those participants who received a calculated HEART Score in the emergency
room to be utilized by the admitting physician, an MD or DO calculated 83% of the scores.
There was one HEART Score that was inaccurately calculated, and an MD completed this.
Provider differences are shown in Table 7.
Table 7
Provider
Group

Participants

Percentage of sample size

Medical doctor/doctor of osteopathy

69

80%

Physician assistant

11

11%

Nurse practitioner

8

9%

Length of stay. The study had a primary purpose of decreasing a patient’s length of stay.
In the study, a small portion of the sample size was placed into an observation status (10%) while
the remaining 90% of participants randomly selected for the study spent greater than 1 day in the
acute care setting after admission. Of the original sample size of 86 participants, 1 participant left
the hospital against medical advice (AMA) while 21% of the study participants spent 3 days or
greater in the hospital, with the largest LOS of 6 days. The overall average LOS for the sample
participants was 1.28 days. Of those participants who were admitted with a calculated HEART
Score, 14 had a HEART Score calculated correctly with an average LOS of 2.14 days.
Participants without a HEART Score had an average LOS of 1.8 days. One participant had a
HEART Score calculated incorrectly and was excluded from the study. There were no
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participants in the sample size that appeared more than once in the random selection process.
LOS differences are shown in Table 8.
Table 8
Length of Stay
Group

Participants

Percentage of sample size

Left against medical advice (AMA)

1

< 1%

Observation or 23-hour admission

9

10%

Admission greater that initial 23 hours but less than
2 full days

35

41%

Admission greater than 2 full days but less than 3
full days

22

26%

Admission greater than or equal to 3 full days

18

21%

HEART Score analysis. Although there are adequate evidence-based research and
clinical support for the utilization of the HEART Score, of the 86 participants in the original
sample size, only 15 had documented risk stratification scores using the HEART Score. One
participant had a risk stratification score that was not calculated correctly, leaving a sample size
of 14 for SPSS statistical analysis. The average HEART Score was 3.57, with an MD calculating
HEART Score in 60% of the qualifying 15 sample charts. Health care providers calculated the
HEART Score in a total of 7 participant charts, with a breakdown of a physician assistant
calculating 27% of the records and a nurse practitioner completing the risk stratification in only
13% of the reduced sample. All of the calculated HEART Scores in the sample were for
Caucasian patients with an age range between 32 and 74 years old. The median age with a
calculated HEART Score was 50. The average age of participants without a calculated HEART
Score was 59. HEART Score differences are shown in Table 9.
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Table 9
HEART Score Risk Stratification
Group

Participants

Percentage of sample size

Utilized

15

17.0%

Not utilized

71

51.0%

Correctly calculated HEART Score

14

99.9%

Among the original sample, there were no patients determined to have an acute STEMI
or an NSTEMI with an elevated troponin. With knowledge of the current policy and procedure
within this hospital, these individuals were being admitted with a diagnosis of STEMI or
NSTEMI versus acute chest pain. Therefore, these patients were not recognized with a diagnosis
code consistent with the random selection of participants in this study.
LOS and HEART Score Data Analysis
According to the independent samples t test analysis completed in SPSS (Version 25)
with the study data, the different groups of comparison were found to be similar to a
disproportionate sample size between the two groups (see Table 10).
Table 10
LOS Group Statistics
HEART Score utilization

N

Mean

SD

SEM

Utilized

14

2.50

1.019

.272

Not utilized

71

2.55

0.983

.117

According to the independent samples t test analysis completed in SPSS (Version 25)
with the study data, the mean LOS was very similar between participants who had a calculated
HEART Score compared to those who did not have a documented HEART Score risk
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stratification (see Table 11). The identified standard deviation is the square root of the variances,
which assists in confirming the difference between the variables. The standard deviation for
participants with the risk stratification (1.019) and those without (0.983) had minimal variance,
leading to the assumption that there was little difference between the two participant groups.
Table 11
Independent Samples t Test
Levene’s test
for equality
of variances

t test for equality of means
95% confidence
interval of the
difference

LOS
Equal
variances
assumed
Equal
variances not
assumed

F

Sig.

t

df

Sig. (2Mean
SE
tailed) difference difference Lower

Upper

.012 .915 –.171

83.00

.865

–.049

.289

–.624

.526

–.166

18.09

.870

–.049

.296

–.672

.573

Another analysis of equality between variables in this study was Levene’s test. This test
provides a significance level of .915, which is much higher than the set 95%, or 0.05, as the
confidence interval applied in the study. With this finding, I accepted the null hypothesis,
assuming that the variables were similar with minimal variance in means.
In analyzing the t test results, I found that the results showed a similar variance of LOS
between participants with a calculated HEART Score and those without this score when admitted
in the acute care setting. With the calculated degrees of freedom, the assumption existed that 83
pieces of data worked independently in the study and contributed to the calculation of the
estimated t test. Another pertinent value provided from this analysis was the p value, p = .05.
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With the 2-tailed significance of 0.865, once again this value was much larger than the p value;
therefore I must accept the null hypothesis. There was no significant difference to support the
assumption that the use of the HEART Score risk stratification tool reduced a patient’s LOS.
Implications of Nursing Practice
Although this study did not have statistically significant results, there were important
findings that supported knowledge building in nursing practice. Advanced practice nurses must
realize the importance of having consistent and standardized evidence-based tools to safely
predict the nature of acute chest pain and be able to quickly establish a plan of care to address an
imminent cardiac disease that is potentially fatal to the presenting patient. Time is critical in the
emergency room when identifying signs and symptoms of life-threatening cardiac symptoms. In
this study, the HEART Score provided a reliable and valid predictable tool in developing a safe
and efficient plan of care for each patient.
The HEART Score tool provided significant key concepts that advanced practice nurses
and other nursing teams could utilize to build nursing practice knowledge. A hospitalist nurse
practitioner needs to recognize key factors that a patient presents with that are clearly outlined in
the HEART Score risk stratification, such as age, previous ischemic cardiac disease, and
significant family history that places a patient at higher risk of cardiac disease when admitted.
Nursing teams must know this tool and the predictability of the results when developing an
appropriate education plan for the safe discharge of a patient. This critical knowledge also builds
on the ability of a nurse and the nurse practitioner to appropriately respond to the fears, anxiety,
and worry that a patient with cardiac-related chest pain carries when being hospitalized and/or
being discharged home. For advanced practice nurses who work directly in the emergency room,
this study provided safe parameters to either discharge a patient home without inpatient acute
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care admission or properly prepare a patient and their family with knowledge regarding the risk
associated with the HEART Score and reasonable expectations of additional testing and
procedures necessary in the acute care setting after admission.
Discussion of Limits for Scope of Practice
After completion of this study, one specific area of concern became clear for advance
practice nurses: The hospital leadership, hospitalist medical director, and emergency room
management must agree on a safe and efficient process and procedure of utilizing a standardized
risk stratification tool for treating acute chest pain patients. Without active participation and
input from the advanced nurse practitioner profession to promote a change in policy and
procedure to utilize such a tool, they are forced to practice according to their supervising and/or
attending physician versus according to their evidence-based knowledge of best practices. This
oversight limits their ability to maintain a set practice of including the HEART Score tool and
other risk stratification tools into their assessment and diagnosis of symptoms such as acute chest
pain. At a higher level, an advanced practice nurse can directly impact medical and nursing
practice policy by actively engaging in furthering research to support the use of risk stratification
tools and positive effects on reducing LOS and health care expenditures, increasing quality of
care, and improving patient outcomes.
Chapter Summary
In conclusion, the results of this study did not show significance between the calculation
of a HEART Score in reducing LOS for a patient who presents to the emergency room and is
admitted with acute chest pain. Statistical data were analyzed through SPSS (Version 25) by
conducting an independent samples t test. The analysis indicated very similar results between the
comparison groups, although the groups were very skewed in size. The sample size and the use
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of the HEART Score among the participants were very low, leaving minimal data to analyze and
determine accurate findings from and reducing my ability to generalize these results to a larger
population. Future studies are essential on this subject to provide additional supporting evidencebased research to strengthen overall patient safety, promote positive patient outcomes, reduce
health care expenditures, and advance knowledge and exceptional care in nursing practice.
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Chapter 5: Discussion, Conclusions, and Recommendations
With the health care system throughout the United States facing continued increasing
expenditures, new policies and procedures need to be implemented to support the reduction of
costs while creating an increased level of patient safety with improved outcomes. According to
Deloitte Touche Tohmatsu (2015), “Health care spending in North America is anticipated to
grow an average of 4.9% annually in 2014–2018” (p. 1). The Institute of Medicine is one entity
among many that have spent decades using evidence-based research to improve overall health
care by controlling costs and improving patient outcomes (Olsen, Saunders, & Yong, 2010). This
study was conducted to develop and create supportive evidence-based research and a reliable
source of knowledge for health care leaders, providers, and nursing teams. Findings from this
study provided evidence-based knowledge to health care leaders to build best-practice standards
for treating patients more safely and efficiently when presenting with signs and symptoms of
ACS. Due to a small sample size, minimal variation in ethnicity representation, and the lack of a
set protocol requiring the treating provider to utilize one of the evidence-based risk stratification
tools (e.g., HEART Score, TIMI, GRACE) for acute chest pain, this researcher did not find
statistical significance to add to the existing body of research to support utilizing the HEART
Score risk stratification tool to decrease patients’ LOS in the acute care setting. Although the
results were not found to be statistically significant, other findings in the study supported a
positive impact on the relationship defined by the DNP Essentials to advance practice with
increased quality systems and improved patient outcomes. After the completion of this project,
there were clear implications for future research and clinical practice changes that could be
implemented and tested in different research designs on this subject.
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Interpretations and Inference of Findings
Although there was no statistical significance in this study, other findings can be
significant in assisting health care leaders, providers, and nursing teams in this hospital and other
hospitals throughout the country. One key result that was present in the study was the
disproportionate number of sample participants with a calculated and documented HEART Score
to access the indicated risk associated with their acute chest pain. As previously defined in the
literature review, there are significant and reliable tools for calculating a patient’s risk for ACS
when being treated in the emergency room. Hospitalist providers can utilize these tools after a
patient is admitted to interpret the results of additional testing and develop an appropriate plan of
care in the acute care setting. The data collected in this study demonstrated a lack of standard
practice among emergency room providers when determining the nature and the significance of
the acute chest pain symptom with the possibility of ACS and life-threatening disease. The
majority of the participants were admitted without a HEART Score calculated and underwent
additional testing without proper support and documentation of risk assessment. The providers
both in the emergency room setting and in the hospitalist setting appeared to routinely admit all
patients with an acute chest pain diagnosis. The developed plan of care for cardiac workup was
standard for all participants, without individualization to the patient. This standard workup was
safe practice for all as determined by consulting cardiologists versus being guided by the
individualized determination of appropriateness from an evidence-based risk stratification
instrument. Further research is needed to assess the impact of fear among providers versus
utilizing reliable and valid risk stratification tools that individualize a safe and efficient plan of
care and/or discharge.
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Strength and Weakness
A strength found in the study was the high level of accuracy (99.9%) in calculating the
risk stratification scores. Providers in the emergency room consistently obtained patient
information and accurately calculated a score that could reliably be used by the hospitalist team.
Only one physician gave a participant a lower HEART Score after not adequately accounting for
previous medical history. However, a major weakness cleared became present in the study at
completion as there was no clear and documented standard of care or directed policy and
procedure for emergency room or hospitalist providers when accessing risk and treating a patient
with acute chest pain. Unfortunately, the random sample size showed only 15 out of 86
participants were admitted with a documented HEART Score after a thorough chart review. This
small proportion of participants received a risk stratification score versus the 71% of the study
subjects without this variable, which created a minimal group of comparison to assume accurate
findings and to generalize results as a whole from the study. For the results to have similar
importance and value to evidence-based research, the comparison groups should be closer in
size.
Implications of Analysis for Leaders
Hospital leadership and other health care management members can utilize these findings
to develop new policies and procedures to assure that each patient is appropriately assessed with
a risk stratification score during the workup in the emergency room. This standard of care can
strengthen the assurance that no findings or patient/family history are missed upon initial
assessment. A low calculated HEART Score could lead providers to feel confident with
immediate discharge. This discharge from the emergency room would avoid unnecessary
inpatient days and unnecessary health care expenditures in the acute care setting that can safely
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be completed in the community setting. However, a HEART Score greater than 3 as determined
in the initial emergency room assessment can immediately alert the provider to a higher
likelihood of ACS as the cause of the presenting symptom and the need to accelerate treatment
modalities for patient safety. The existing evidence-based research behind the utilization of these
tools can assist leadership in changing clinical practice standards and potentially reducing overall
health care costs for the institution, including a reduction of LOS.
Hospital leaders can also utilize the study findings to enhance provider and nursing team
education. The literature review in this study provided significant information as to different
components of each of the three main risk stratification tools and appropriate application to the
clinical setting. This knowledge, along with the study findings, prepares a health care provider in
developing an efficient, safe plan of care. This also supports nursing practice in developing an
appropriate individualized nursing care plan. With the conversation related to the focus on
reducing a patient’s LOS, pertinent training and education materials can be developed based on
study findings and presented to different provider groups, clinical management, clinical leaders,
and nursing teams to enhance their awareness of the key factors and areas that they can
personally impact toward this goal. Many different components of care can be safely
manipulated with risk stratification knowledge and can have a direct impact on the LOS,
including patients with the diagnosis of acute chest pain.
Essentials of Doctoral Education for Advanced Practice Nurses
After completing this retrospective chart review study by analyzing the collected data and
presenting the literature review of previously existing research on the HEART Score and other
risk stratification tools for ACS management, I identified potential findings that support health
care cost reduction by decreasing LOS. Although the data analysis did not show statistical
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significance in this particular study, some factors supported a relationship between other findings
and the DNP Essentials.
Essential 1: Scientific underpinnings for practice. This study provided significant
implications for utilizing evidence-based knowledge to support the implementation of risk
stratification tools such as the HEART Score. Through policy and procedure changes,
standardizing advanced practice nursing becomes essential in the assessment process of
diagnosis and proper patient care planning. As found in this study, specific policy and procedural
changes will be created by evaluating further scientific results on nursing practice related to
establishing and implementing an appropriate care plan. As supported by the associated theory of
unpleasant symptoms utilized for this study, nursing teams and providers will be able to address
not only the physical needs of a patient with acute chest pain but also the fears and anxiety
related to symptoms of ACS. With this approach of standardization, the nursing practice will be
encouraged to recognize and educate on the impact of physical symptoms, emotional behaviors,
and patients’ understanding of their environment.
Essentials II: Organizational and systems leadership. A relationship is clear from this
study, leading the organization as a whole and its leaders to create methods of improving the
quality of care for patients. There is a need for providers, both in the emergency room and in the
inpatient hospital setting, to utilize risk stratification tools. With these tools, providers strengthen
the accuracy of a patient’s diagnosis, justify the severity of the diagnosis, and assist in
developing a high-quality plan of care with cost-containing components appropriate for the
inpatient setting. Another impact of this research allowed key stakeholders to recognize and
focus on the need for clinical practice standard of care system redesign to improve patient
outcomes.
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Essential III: Clinical scholarship and analytical methods. This study further supports
the development of research to support best practices in the medical and nursing professions.
Through a detailed literature review and completion of this study, utilization of risk stratification
tools in the diagnosis of cardiac-related chest pain is important in changing practice guidelines to
improve patient safety, cost-containing efforts, and quality of care, and create an individualized
plan of care for each patient. Many risk stratification tools can be easily accessed during a time
of required rapid assessment and diagnosis to enhance overall clinical quality and safety in care.
Another valuable advancement from this study is further utilization and support of SPSS
(Version 25), which provides many different testing methodologies based on independent and
dependent variables identified in health care studies. Specific to this study, there is support in
using the independent samples t test to formulate data collected and quickly translate findings
into a statistical analysis. The inclusion of this analytical method and modality can advance and
strengthen all medical and nursing topics under review.
Essential IV: Information systems and patient care technology. In this study, a quick
and reliable verification of the HEART Score calculation was conducted for each participant by
utilizing a downloaded mobile application. This technology can be utilized in patient education
processes to assist in early recognition of their risk stratification score when experiencing an
episode of acute chest pain. Hospitalist group providers can utilize this convenient technology to
verify the accuracy of HEART Score calculations and determine an appropriate plan of care
when accepting a new admission from an emergency room provider. The valuable information
obtained through this technology can support their diagnosis and care plan development when a
patient’s condition suddenly changes while in the inpatient setting.
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Essential V: Health care policy. With the expansion of this study and its results,
advanced nursing professionals can expand new knowledge to other settings on a broader
spectrum. Through the presentation and practice of utilizing the HEART Score and other risk
stratification tools, nursing professionals can impact health care policy change at a national level
in recognizing and efficiently treating cardiac disease and its presenting symptoms. Through
these efforts, the advanced nurse practitioner can be key in reducing health care expenditures,
improving patient safety, and supporting overall positive outcomes. Further research is essential
in diverse health care settings on this subject to avoid generalizing best practices without
studying this method in larger populations with a higher degree of ethnicity and racial
differences.
Essential VI: Interprofessional collaboration. Patient outcomes are a key component
as identified in DNP Essential VI and relate to this study by presenting the need to make changes
to the present management of symptoms in this environment and potentially in many other acute
care institutions that do not have a practicing protocol to assess and treat a patient with acute
chest pain. Communication and collaboration across multiple professions in the acute care
setting are essential in developing and quickly implementing a plan of care for an individual with
a higher HEART Score. All team members must know the meaning behind the different risk
scores and how these calculations relate to the critical, time-sensitive, essential changes in a
patient’s plan of care, their individualized education needs for enhanced understanding of their
disease, their overall health status, and the future response to similar episodes. The findings from
the study indicate the need for further research on this subject to impact medical and nursing
practice interventions and this specific DNP Essential.
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Essential VII: Clinical prevention and population health. A clear relationship is
presented from the findings of this study in improving patients’ understanding and response to
episodes of acute chest pain. With a verified HEART Score, the patient can be properly educated
by the medical and nursing teams on the meaning and cause of presenting symptoms, essential
lifestyle changes to lower their risk of developing or progressing cardiac disease, and the ability
to manage their overall health with more confidence. With proper education and health
promotion, the patient can move forward with confidence about the disease behind this symptom
and adjust their response to further episodes of chest pain. A standardized practice for the
diagnosis and treating acute chest pain through the use of the HEART Score risk stratification
tool can improve overall individual, community, and general population health with proper
understanding and education from health care professionals.
Essential VIII: Advanced nursing practice. This study has a direct relationship with
the advanced practice nurse when practicing in the emergency room, as an inpatient hospitalist,
as an internal medicine provider, or in the outpatient cardiac setting. The need for further
evidence-based knowledge and advanced specialization in cardiac-related disease signs and
symptoms is increasing throughout the country. Early recognition, accurate validation of risk
scores, and efficiency of treating by the advanced nursing practice become essential as cardiac
disease now presents across all age groups, racial groups, ethnicity classifications, and gender
groups. Through the use of this study and other evidence-based research across different
professions, there is a need for standardized risk assessment tools to be implemented in
comprehensive assessment practices of acute chest pain symptoms.
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Recommendations for Future Project
For the future expansion of this study to support the research that already exists, it would
be important to conduct a study with a larger sample size. This study was conducted in a
suburban community hospital with providers who individually determined the importance of
utilizing and documenting a risk stratification score for their patients. In addition to the
methodology utilized in this study, a qualitative approach could be added, interviewing
physicians and other health care providers in the emergency room and working as a part of the
hospitalist team to gain knowledge about their understanding of different risk stratification tools,
their willingness to utilize the HEART Score tool in their standard practice, and their explanation
of their beliefs and comfort behind the scores obtained in the HEART Score versus one of the
other cardiac risk stratification tools. Another recommendation for further research would be to
conduct this same project in a facility and/or multiple facilities with a set standard of care and
predetermined procedural protocols for treating patients who present with acute chest pain in the
emergency room. With larger data sets, there would be stronger evidence as to whether or not the
HEART Score tool directly impacts the LOS for an admission.
Additional research is indicated on the subject of reducing a patient’s LOS with the use
of a risk stratification tool such as the HEART Score. One recommendation for future research
on this subject is to duplicate the methodology and analysis utilized in this study in a much larger
inpatient institution with a more diverse patient population. In selecting the appropriate
institution, the researcher would benefit from assessing and evaluating current protocols of
practice among the emergency room providers and the hospitalist providers to determine if risk
stratification tools are part of the management for acute chest pain. Another recommendation for
research would be to complete the same study with a much larger sample size and diversify the
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study to include the utilization of not only the HEART Score but also the TIMI and the GRACE
risk stratification tools and the impact on LOS. There is a current body of existing research on
the effects of risk stratification scores on LOS, but the volume is not very expansive.
Additional research also needs to be conducted to further strengthen and support
evidence-based knowledge of the HEART Score tool and its impacts on nursing practice. When
the HEART Score is calculated and interpreted properly during the care of a patient with cardiacor non–cardiac-related chest pain, the nursing plan can have a more direct impact on future
outcomes. Through emotional and physical nursing care, a patient with chest pain can receive
individualized care, comfort, and pertinent education to recognize factors in determining the
significance of early symptoms of cardiac-related pain. This knowledge will properly prepare a
patient for future episodes with knowledge of early intervention and proper management. To
improve the quality of care, advance medical and nursing knowledge, and reduce health care
expenditures through this method, more research is needed to significantly support the existing
research.
Chapter Summary
In conclusion, there is an increasing national health care focus to reduce growing health
care expenditures through methods to improve the quality of services and redesign clinical
practice to avoid unnecessary high-cost medical tests, limit hospital inpatient days, and improve
overall patient outcomes. The utilization of the HEART Score risk stratification tool and other
evidence-based tools has different impacts that align with the national focus when utilized in the
care of a patient with acute chest pain. Although I did not find statistical significance due to
multiple limitations, many pertinent findings support a direct reduction of LOS and associated
unnecessary expenditures. Health care leadership and management can utilize this study to
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determine and support the need for standardizing clinical practice and procedure to assure a
higher quality of care for patients with ACS or presenting with the potential of a new ACS
diagnosis. The need for advanced clinical training and education of providers and nursing teams
has been enhanced with the findings of this study. Clinical practice knowledge should focus on
key factors in quickly identifying symptoms of ACS and creating a plan of care to best support
each patient while managing health care costs, improving quality of care, and improving patient
outcomes. Further research in the future is essential for the continued support of the need to
standardize the use of the HEART Score risk stratification to directly impact the LOS in the
acute care setting.
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Appendix B: Clinical Site Support Letter
Abilene Christian University
16633 North Dallas Parkway Ste 800
Addison, Texas 75001
January 24, 2019
To Whom It May Concern:
This letter is written of my intended support for the project proposal by Kelly Huffman,
ARNP regarding the effects of utilizing the HEART Score risk stratification tool to reduce the
length of stay for patients with the chief complaint of acute chest pain once admitted to the
hospitalist program.
Through active leadership and mentoring to advance research within the hospitalist role
and reduce unnecessary hospital days, it is my pleasure to support this project. I am confident
that the project outline, implementation, and analyses will prove useful for both current and
future research in this arena.
It is my privilege to support Ms. Huffman in her initiative to engage and develop this
capstone project. If you have any questions or concerns, please do not hesitate to contact me.
Sincerely,
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Appendix C: Clinical Site Consent Form
CONSENT FOR DATA COLLECTION
I am a doctorate-nursing student at Abilene Christian University conducting a study to determine
the effects of the HEART Score tool on a patient’s length of stay. This document once signed,
will provide permission to obtain only necessary information as laid out below for each patient
chosen to participate in this study.
Healthcare expenditures are rapidly growing. As healthcare providers in acute care, we must
look at different methods of providing care and eliminate unnecessary inpatient hospital days,
expensive testing and utilize tools to reliably complete diagnosis. With knowledge and practical
application of cardiac tools such as the HEART Score tool during diagnosis, hospitalist providers
can make a direct impact on reducing healthcare expenditures while reliably and rapidly
transitioning these patients back to the outpatient setting. This project will analyze the ability to
reduce a patient’s length of stay with knowledge of a HEART Score provided on admission. A
retrospective chart review will be completed for all eligible participants between January 1,
2017, and December 31, 2018. There will be 71 randomly selected charts from XXXXXXXXXX
utilized to obtain data in this study. The focus of the study will be to determine whether an initial
cardiac risk stratification tool was utilized and how this data was able to reduce a patient’s length
of stay. Significant findings will lead to further evidence regarding the use of the HEART Score
risk tool to shorten inpatient hospital stays.
Your permission has been requested to access all randomly selected charts for data collection.
This form provides important information about the study, including the risks and benefits of the
study. Please read this form carefully and ask any questions that you may have regarding the
procedures.
PURPOSE AND DESCRIPTION:
The purpose of this study is to review 71 patient charts that have been admitted for acute chest
pain. Data will be obtained from these charts to determine whether a HEART Score was
calculated prior to admission and what testing was completed during the period of admission.
The final area of interest for each chart will be the total length of stay for each participant.
Participants are not required to provide consent to chart review as this is a retrospective review
and all care has been completed at the time of discharge. Therefore, there is no risk or benefit to
the individual participants.
The research will be labeling each chart by a number code. There will be no private health
information or demographic information obtained or shared during data collection, analysis or
report of findings. You and the researcher will be the only individuals that have access to
personal patient identifiers and demographics.
The following provides specific information that will be drawn from each chart review:
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For patients:
HEART Score will be assigned (1)
Without a HEART Score will be assigned (2).
Quantify the specifics for each patient,
Observation or 23 hr admission= 1,
Admission greater that initial 23 hours but less than 2 full days= 2,
Admission greater than 2 full days but less than 3 full days= 3,
Admission greater than or equal to 3 full days= 4.
Provider calculating HEART Score:
Medical Doctor/ Doctor of Osteopathy = A
Healthcare provider (NP or PA) = B
RISKS & BENEFITS:
There are no identified risks of taking part in this research study.
There are potential benefits to participating in this study. Such benefits may include further
research to identify concepts that delay a patient’s length of stay. Further support for utilizing
cardiac risk factor tools when developing an appropriate and safe plan of care for each patient
and further evidence-based research allowing for hospitalists and nursing staff to properly
educate and prepare patients for safe discharge. The researcher cannot guarantee that you will
experience any personal benefits from participating in this study.
PRIVACY & CONFIDENTIALITY:
Information collected about each participant will be handled in a confidential manner in
accordance with the law. There will be no identifiable data to be shared with individuals outside
of the study team, such as members of the ACU Institutional Review Board or healthcare entities
seeking to publish research findings. Each chart will be accessed from between 30 to 45 minutes
and will no longer be needed after data is collected.
COLLECTION OF IDENTIFIABLE PRIVATE INFORMATION OR BIOSPECIMENS:
After identifiers are removed, participant data may be used for future research, including by
other investigators, without obtaining further consent from you.
CONTACTS: If you have questions about the research study, the Principal Investigator is Kelly
Huffman, ARNP AG-BC and may be contacted at XXX-XXX-XXXX,
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XXXXXXXX@XXXXXX. If you are unable to reach the Principal Investigator or wish to speak
to someone other than the Principal Investigator, you may contact XXXXXX XXXXXXXX at
XXXXXXXX@XXXXXX If you have concerns about this study or have general questions
about your rights, you may contact ACU’s Chair of the Institutional Review Board and
Executive Director of Research, Megan Roth, Ph.D. Dr. Roth may be reached at
XXXXXXX
XXXXXXXXXXXXXXX
320 Hardin Administration Bldg, ACU Box 29103
Abilene, TX 79699
Your support and approval in this research are entirely voluntary.
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Appendix D: IRB Exception Letter
Dear Kelly,
On behalf of the Institutional Review Board, I am pleased to inform you that your project
titled (IRB# 19-039) is exempt from review under Federal Policy for the Protection of Human
Subjects.
If at any time the details of this project change, please resubmit to the IRB so the
committee can determine whether or not the exempt status is still applicable.
I wish you well with your work.
Sincerely,
Megan Roth, Ph.D.
Director of Research and Sponsored Programs Additional Approvals/Instructions:

The following are all responsibilities of the Primary Investigator (PI). Violation of these
responsibilities may result in suspension or termination of research by the Institutional Review
Board. If the Primary Investigator is a student and fails to fulfill any of these responsibilities, the
Faculty Advisor then becomes responsible for completing or upholding any and all of the
following:
• If there are any changes in the research (including but not limited to change in location,
members of the research team, research procedures, number of participants, target
population of participants, compensation, or risk), these changes must be approved by
the IRB prior to implementation.
• Report any protocol deviations or unanticipated problems to the IRB promptly
according to IRB policy.
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• Should the research continue past the expiration date, submit a Continuing Review
Form, along with a copy of the current consent form and a new Signature Assurance
Form approximately 30 days before the expiration date.
• When the research is completed, inform the Office of Research and Sponsored
Programs. If your study is Expedited or Full Board, submit an Inactivation Request
Form and a new Signature Assurance Form. If your study is Exempt, Non-Research, or
Non-Human Research, email to indicate that the research has finished. orsp@acu.edu
• According to ACU policy, research data must be stored on ACU campus (or
electronically) for 3 years from inactivation of the study, in a manner that is secure but
accessible should the IRB request access.
• It is the Investigator’s responsibility to maintain a general environment of safety for all
research participants and all members of the research team. All risks to physical,
mental, and emotional well being as well as any risks to confidentiality should be
minimized.
For additional information on the policies and procedures above, please visit the IRB website
http://www.acu.edu/community/offices/academic/orsp/human-research/overview.html or email
XXXXXXXX with your questions.
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Appendix E: DNP Project Timeline
January 2018
January through February 2018
February 2018
February 2018
February 2018
February through June 2018
June 2018
July through August 2018
September through November 2018
September 2018 through January 2019

January 2019

January 2019

January and February 2019
February 2019
February 2019
March through April 2019

April through June 2019

June 2019
June through September 2019
September 2019
October through December 2019

Project development and project design
Began DNP Project research and development of
PICOT statement and Introduction drafting
Theoretical Framework research and development
Methodology research and development with
tracking tool development
Validation tool research
Literature review
PICOT research, development, and final drafting
Statistical research and knowledge development
Chapter 1 and 2 development, editing, and drafting
Chair and committee development and initial
meetings, prepared Project Chair and Committee
form and submitted for approval to ACU Program
Director
Completed initial chapters 1-3 of DNP project
paper, provided a copy for project chair and
committee members to review, made recommended
content and formatting changes
Facility site secured with affiliation agreement
completed, Medical Director letter of support
processing, ePortfolio development
Drafting and final editing of PICOT, Literature
Review, and Methodology Chapters
Review of DNP hour e-log reviewed by Project
Chair
IRB training completed
Finalization of DNP Project and DNP Proposal
Defense Presentation, multiple meetings with Chair
and submitted signed form for DNP Proposal
Defense, editing based on Chair and committee
recommendations, secured signed Proposal Defense
Project completion form
IRB proposal and submission with signature from
Facility Chair, on June 13, 2019 received exempt
approval by ACU IRB and Facility IRB exempt
status received on May 25, 2019
Random selection of participants completed by
Medical Director
Retrospective chart review, data collection for 86
randomly selected participants
Data management and de-identifying
Data validation and analysis
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December 2019 and January 2020
December 2019 and January 2020

January 2020
January 2020
February 2020

Verification of data analysis and result findings
Drafting and editing of Chapters 3 through 5,
Inactivation Form processed, Raw data submitted to
ACU with no identifying components
Submitted to private editor, made recommended
changes of content and formatting
Permission for Final Defense Proposal received and
Final Defense Presentation completed
Announcement of Final Defense Presentation
confirmed and out for final signature, approval,
completion of recommended changes, final approval
of committee, chair, and program leaders
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Appendix F: Permission To Use MDCalc Tools
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Appendix G: Permission To Use Conceptualization Tool
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